$RBRK

THOMPSON JOHN WENDELL sold $338K of RBRK

THOMPSON JOHN WENDELL sold 4,000 shares of Rubrik, Inc. (RBRK) at $84.41 ($0.34M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · THOMPSON JOHN WENDELL
Published Jun 4, 2026, 1:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBRK
Neutral
medium confidence
Mentioned
$RBRK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBRKNeutralLow
01

Why it matters

Traders may monitor whether this is part of a broader pattern of insider selling or whether future filings show net buying.

02

Market read

A director’s 10b5-1 sale is generally not a standalone catalyst, but it can marginally influence short-term sentiment around RBRK.

03

What to watch

Magnitude is modest relative to typical institutional float; without accompanying buys/sells by other insiders or changes in option exercises, the signal is weak.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed June 3; sale executed June 1

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by a director with a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$RBRKNeutralMedium confidence
Context

Rubrik director John Wendell Thompson sold 4,000 shares in an open-market transaction disclosed via SEC Form 4 on June 1, 2026.

Expected impact

Likely limited immediate price impact; any effect would be sentiment-driven and short-lived unless followed by additional insider activity.

Evidence & confidence

The filing is an ownership-change disclosure (not earnings/M&A/regulatory). The sale is explicitly tied to a pre-arranged 10b5-1 plan, which reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider activity without new operational/regulatory information.

Minimal; US-listed single-name disclosure.

Low; no cross-border transaction or macro/regulatory linkage.

Counterpoint

The sale could reflect routine liquidity needs rather than bearish expectations; 10b5-1 plans are often used specifically to avoid signaling.

Key entities

  • Rubrik, Inc.

    US-listed company whose director disclosed an open-market sale of shares via SEC Form 4.

  • THOMPSON JOHN WENDELL

    Director of Rubrik who sold 4,000 shares at $84.41/share under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RBRKMed

Here's How Rubrik Stock Gained 28.6% Last Month

Rubrik (RBRK) rose 28.6% in August 2026, driven by a cybersecurity rally and strong earnings. Q2 2027 earnings showed a profit of $0.20 per share and 41% revenue growth. The stock trades at 12.7x sales and 68x free cash flow, with analysts calling the post-earnings drop a buying opportunity. The company's growth and market position make it appealing despite its high valuation and volatility.

$RBRKMed

Jim Cramer on Rubrik (RBRK): “It Just Came in Maybe Too Hot”

Rubrik, Inc. (RBRK) reported Q2 fiscal 2027 revenue of $427.3M, up 38% YoY, beating estimates. EPS was $0.20, above consensus. Subscription ARR rose 33% to $1.66B. Guidance was raised. Despite strong results, shares dropped 13% post-earnings, possibly due to high expectations. Free cash flow grew 14% YoY, but margins declined. Hedge fund holdings decreased slightly, and short interest is around 9%.

$RBRKMed

Rubrik’s AI Security Bet Could Power the Next Leg Higher

Rubrik reported Q2 earnings with adjusted EPS of $0.20, beating estimates by $0.16. Revenue and earnings guidance exceeded expectations. Analysts raised price targets, with a consensus near pre-release highs. Institutional investors have been accumulating shares. Risks include high valuation and competition, notably from Microsoft. The company expects GAAP profitability by 2028.